Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity

Khalid Abozguia1, Ganesh Nallur-Shivu, Thanh T Phan

  • 1Department of Cardiovascular Medicine, University of Birmingham, Edgbaston, United Kingdom. abozguia@gmail.com

Insights

Reduced left ventricular strain and delayed untwist significantly impair exercise capacity in nonobstructive hypertrophic cardiomyopathy (nHCM) patients, despite normal ejection fraction. These findings highlight key factors contributing to exercise limitation in nHCM.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Echocardiography

Background:

  • Nonobstructive hypertrophic cardiomyopathy (nHCM) often presents with reduced exercise capacity.
  • Left ventricular ejection fraction may appear normal in nHCM patients, masking underlying functional deficits.

Purpose of the Study:

  • To investigate left ventricular strain, twist, and untwist as predictors of exercise capacity in nHCM.
  • To compare these parameters between nHCM patients and healthy controls.

Main Methods:

  • Echocardiography with 2D speckle tracking was used to measure strain, strain rate, rotation, twist, and untwist in 56 nHCM patients and 43 controls.
  • Peak oxygen consumption (peak Vo(2)) was measured to assess exercise capacity.

Main Results:

  • nHCM patients showed significantly lower peak Vo(2) compared to controls (23.28 vs 37.70 mL/[kg min]).
  • Reduced longitudinal, radial, and circumferential strain, delayed untwist, and lower rotation rates were observed in nHCM patients.
  • Longitudinal strain rate and 25% untwist significantly correlated with peak Vo(2).

Conclusions:

  • nHCM is characterized by widespread systolic and diastolic functional abnormalities.
  • Reduced strain and delayed untwist are significant contributors to exercise limitation in nHCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...